The first cardiac rehabilitation (CR) programmes appeared around the 1960s when Turell and Hellerstein advocated comprehensive rehabilitation for patients recovering from acute cardiac events. 1 The focus was on the successful integration of patients back into society, improving recovery times and functional status, and reducing the hospital stay; therapeutic exercise was the core component of CR. Since then, CR has undergone profound changes, with programmes now embracing secondary prevention activities 2 and covering a wide spectrum of cardiovascular conditions. Today, CR and prevention programmes include patients post-percutaneous coronary intervention, after cardiac surgery including heart transplantation (HT), and with chronic heart failure (HF). 3 Hence, the CR revolution has occurred in two directions: the type of interventions offered and type of patients referred. The management of patients with recent ventricular assist device (VAD) implantation represents a natural and legitimate development for contemporary CR and prevention programmes.
The ventricular assist device patient
For many years, HT was the only proven therapy for end-stage HF, but it has been, and in the foreseeable future will continue to be, severely limited by the availability of donor hearts. 4 In recent years, VADs have revolutionized the treatment of these patients. 5 Three categories of VAD patients have emerged: 6 (1) individuals requiring temporary circulatory support after a cardiac insult who are expected to recover and not need HT (bridge to recovery); (2) patients awaiting HT but who would not survive the wait until an organ is available owing to low cardiac output and/or noncardiac comorbidities (bridge to transplantation); (3) individuals who need long-term support but have a relative or absolute contraindication to HT (destination therapy). The Interagency Registry for Mechanical Assisted Circulatory Support (INTERMACS) was set up in 2005 to track, refine and optimize outcomes for VAD patients in the United States. 7 The third INTERMACS Annual Report has a data base of about 2800 patients gathered over a period of 5 years; the report has observed, besides the transition from pulsatile-flow to continuous-flow pumps, a decrease in the percentage of patients implanted in critical cardiogenic shock and an increase in those treated as destination therapy, these latter patients registering an impressive improvement in medium-term survival. Since VADs are expected to increase in the long term, the care of VAD patients will gradually shift away from surgeons toward cardiologists. While the initial surgery will remain the responsibility of surgeons, cardiologists are more and more being confronted with the need to handle VAD patients and cope with the inherent risks involved in VAD use. In the pre-and peri-implantation period, specific knowledge, skills and expertise are required, 8 and the cardiologist must have a thorough understanding of prognosis and be fully versed in the application of conventional evidenced-based therapies prior to the use of VADs -including neurohumoral blockade, revascularization, valve repair, implanted cardioverter defibrillator, cardiac resynchronization therapy -and procedures such as ventricular aneurysmectomy or ventricular remodeling. In addition, the cardiologist must be familiar with both VADs and surgical interventions and must have experience regarding pulsatile versus axial/continuous flow devices, intracorporeal versus extracorporeal support, left ventricular versus biventricular or total artificial heart support, and with the mechanical problems related to the VAD as well as alarms interpretation. 8 Finally, competence implies understanding and interpretation of potential complications, such as supraventricular and ventricular arrhythmias pertinent to the device, suction events with axial flow devices, haematological issues, including bleeding and thrombosis associated with antiplatelet and anticoagulant therapy, device-related haemolysis, and infectious complications.
Cardiovascular rehabilitation and prevention for long-term management
Although pre-and peri-operative management is important and VAD patients will always require the attention of specialized HF centres, longitudinal management is crucial for a successful outcome. VAD patients face a unique set of challenges and stressors outside the 'implantation' hospital. 9 The ultimate success of a VAD depends on a clinical approach aimed at encouraging myocardial recovery (including both pharmacological and non-pharmacological options), on the management of nutritional deficiency, evaluation of psychosocial status and quality of life, and prescription of an individualized exercise regimen. In addition, an accurate preparation of patients and their caregivers for the return home is crucial, and should be based on the following premises: (1) reliable compliance; (2) continued education on routine self-care; (3) interpretation and management of device alarms, inspection of the connectors and ventilator filter for dirt or debris, and assessment of the status of the batteries; (4) identification of harmful environments and electrical utilities; (5) prevention of infection, including changing the dressing at the exit site and inspecting for signs of infection; and (6) anticoagulant monitoring. 10 Finally, the primary care physician and local first responders and emergency department personnel should be informed. 11 Although many VAD programmes have established outreach programmes that teach first responders basic issues concerning troubleshooting and pump stoppage, 11,12 a cardiologist with special expertise in VAD patient management should be available to provide ongoing education, particularly in cardiopulmonary resuscitation and cardiac defibrillation.
The VAD patient as such epitomizes the need to shift the emphasis of management away from the acute episode towards a chronic condition. The effectiveness of management ultimately depends on the patient's actions, especially on his or her adherence to drug therapy (see anticoagulation therapy), exercise regimens and response to symptoms, care of the device and knowledge about device alarms. In short, the patient's recovery from VAD implantation is a complex and demanding challenge for both specialists and the healthcare community. In the long term, the VAD patient requires disease management that relies on a specialized professional team, with a detailed clinical protocol, continuity of care and adequate followup algorithms. The integration of CR and prevention into comprehensive programmes responds to this requirement. 13, 14 The CR and prevention programme -as a multifaceted and multidisciplinary intervention, limiting the psychological effects of VAD, maintaining independence with an emphasis on quality of life and on exercise prescription and monitoring, 15, 16 educating patients and applying the appropriate medical therapy, and with a flexible open access -offers a promising new management approach for VAD patients. 17 As regards VAD care strategies, biventricular (BVAD) support deserves a specific mention, since it usually requires the use of large and cumbersome external devices that oblige BVAD patients to remain in hospital for longer periods: residential rehabilitation as a setting for this might be a cultural, structural and cost-effective option in the contemporary medical environment. VAD care provides an opportunity for CR and prevention specialists, as well, to refine conventional preventive and rehabilitative models, improve professional training and experience, revamp or revise the exercise prescription paradigms, improve pharmacological approach and monitoring, and increase cooperation between health care professionals and services involved.
In short, the management and supervision of VAD patients involves a number of challenges and opportunities (Table 1) . We believe that, while this is a difficult task, it is also a positive opportunity in the hands of the European Association of Cardiovascular Prevention and Rehabilitation. Besides the intrinsically fascinating scientific and pathophysiological nature of VAD, orienting the CR and Prevention Service for these patients allows to bring into play the knowledge base, competence, spirit of innovation, competitive strength and collaborative spirit that pervade the members of the association. This new and alternative approach will be a platform for working together in a constructive relationship with other health care societies.
In conclusion, the lengthening of the waiting time for HT due to donor shortage increases the interest in alternative forms of cardiac replacement therapy, either as temporary bridges to transplantation or as a definitive destination strategy. This field is likely to progress quickly, and benefit both survival and functional status. The CR and Prevention Service with its distinctive structured organization and flexible multidisciplinary plan has the potential to face the several challenges of VAD patient management. Although most structures are unwilling to take on this challenge due to clinical difficulties and a lack of training or knowledge, the management of VAD patients is a new frontier. The time has arrived to convert challenges into opportunities. Medication and changing of the dressing at the exit site of the external lead going to the controller console and power packs.
Assessment of myocardial recovery with both pharmacological and non-pharmacological options.
Prevention and management of infection. Promotion of psychological recovery. Management of nutritional deficiency.
Promotion of patient and caregiver education. Supervision of end-organ function.
Arrangement of discharge plan, communication with the primary care physician, local first responders and emergency department personnel. Device failure and interpretation of alarms.
Instruction of community health care workers to treat a cardiac arrhythmia or perform cardiopulmonary resuscitation outside the hospital environment. Education and training of health care professionals involved in VAD care.
Implementation of long-term care and follow-up utilizing a multidisciplinary approach and flexible open access. Encouragement and support of a speculative approach and research lines, such as the need for circadian variation and exertional adaptation of permanent mechanical circulatory assist devices.
